The Epsilon Group (TEG) is a modeling, analytics, and simulation services company committed to improving the understanding and management of disease with the ultimate goal of improving healthcare development and delivery. To this end, TEG provides proprietary bio-simulation services and software (SAAM II and T1DMS) which enable physiologically-based modeling of a wide range of problems in the lab and translational research.

TEG’s primary area of expertise is glucose-insulin metabolism in health and disease – including Type 1, Type 2 and Pre- Diabetes. As such, TEG offers simulation and consulting services for development and optimization of diabetes-specific treatments, protocols, and devices using a specialized (and unique) toolkit. This toolkit features the Type 1 Diabetes Metabolic Simulator (T1DMS) in conjunction with the FDA-accepted in silico patient population.

How TEG Solutions can help you


Life Sciences and Pharma
Develop physiologically-based pharmacokinetic/pharmacodynamic models, test control algorithms, simulate clinical trials and examine outcomes to optimize therapy and eliminate non-viable solutions cost-effectively.


Simulate interventions and management of diabetes and related disease processes to optimize care delivery and disease management.


Utilize latest compartmental analysis and mathematical modeling techniques to educate future healthcare providers, engineers and researchers across many disciplines.